Assenagon Asset Management S.A. Revance Therapeutics, Inc. Transaction History

Assenagon Asset Management S.A.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 17, 2024	SELL	$5.81 - $11.2 $1.25 Million - $2.41 Million	-215,209 Reduced 51.98%	198,846 $1.75 Million
Q3 2023 Nov 06, 2023	BUY	$11.47 - $25.07 $4.75 Million - $10.4 Million	414,055 New	414,055 $4.75 Million
Q1 2023 Apr 18, 2023	BUY	$18.36 - $35.27 $46,854 - $90,009	2,552 Added 1.33%	194,911 $6.28 Million
Q4 2022 Jan 12, 2023	SELL	$18.32 - $30.66 $7.02 Million - $11.7 Million	-383,205 Reduced 66.58%	192,359 $3.55 Million
Q3 2022 Oct 27, 2022	BUY	$14.33 - $28.47 $6.38 Million - $12.7 Million	444,916 Added 340.55%	575,564 $15.5 Million
Q2 2022 Jul 27, 2022	BUY	$11.52 - $20.4 $96,641 - $171,135	8,389 Added 6.86%	130,648 $1.81 Million
Q1 2022 Apr 25, 2022	BUY	$12.36 - $20.31 $41,962 - $68,952	3,395 Added 2.86%	122,259 $2.38 Million
Q4 2021 Feb 01, 2022	BUY	$12.46 - $27.87 $1.48 Million - $3.31 Million	118,864 New	118,864 $1.94 Million
Q3 2021 Oct 19, 2021	SELL	$25.78 - $33.21 $3.66 Million - $4.71 Million	-141,825 Closed	0 $0
Q2 2021 Jul 15, 2021	BUY	$26.8 - $31.84 $3.8 Million - $4.52 Million	141,825 New	141,825 $4.2 Million
Q2 2020 Jul 21, 2020	SELL	$12.6 - $26.55 $206,325 - $434,756	-16,375 Closed	0 $0
Q1 2020 Apr 17, 2020	BUY	$12.46 - $27.81 $204,032 - $455,388	16,375 New	16,375 $242,000

232

82.1M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.